DK41484D0 - Beta-phenethanolaminer og deres anvendelse - Google Patents

Beta-phenethanolaminer og deres anvendelse

Info

Publication number
DK41484D0
DK41484D0 DK0414/84A DK41484A DK41484D0 DK 41484 D0 DK41484 D0 DK 41484D0 DK 0414/84 A DK0414/84 A DK 0414/84A DK 41484 A DK41484 A DK 41484A DK 41484 D0 DK41484 D0 DK 41484D0
Authority
DK
Denmark
Prior art keywords
phenethanolamines
beta
Prior art date
Application number
DK0414/84A
Other languages
English (en)
Other versions
DK171627B1 (da
DK41484A (da
Inventor
David Bennett Anderson
Klaus Kurt Schmiegel
Edward Lee Veenhuizen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK41484D0 publication Critical patent/DK41484D0/da
Publication of DK41484A publication Critical patent/DK41484A/da
Application granted granted Critical
Publication of DK171627B1 publication Critical patent/DK171627B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
DK041484A 1983-01-31 1984-01-30 Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf DK171627B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46258783A 1983-01-31 1983-01-31
US46258783 1983-01-31

Publications (3)

Publication Number Publication Date
DK41484D0 true DK41484D0 (da) 1984-01-30
DK41484A DK41484A (da) 1984-08-01
DK171627B1 DK171627B1 (da) 1997-03-03

Family

ID=23836986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK041484A DK171627B1 (da) 1983-01-31 1984-01-30 Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf

Country Status (25)

Country Link
EP (2) EP0117647B1 (da)
JP (1) JPS59155343A (da)
AU (1) AU577271B2 (da)
BG (1) BG60752B2 (da)
CA (2) CA1247451A (da)
CY (2) CY1433A (da)
DE (2) DE3473439D1 (da)
DK (1) DK171627B1 (da)
FI (1) FI81713C (da)
GB (2) GB2133986B (da)
GR (1) GR79758B (da)
GT (1) GT198400014A (da)
HK (1) HK39090A (da)
HU (1) HU190526B (da)
IE (1) IE56843B1 (da)
IL (1) IL70813A (da)
MX (1) MX9203041A (da)
MY (1) MY100559A (da)
NZ (1) NZ206985A (da)
PH (1) PH20912A (da)
PL (1) PL144053B1 (da)
SG (1) SG4190G (da)
SU (1) SU1523043A3 (da)
UA (1) UA8350A1 (da)
ZA (1) ZA84721B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
NZ212204A (en) * 1984-06-04 1988-07-28 Merck & Co Inc Growth-promoting compositions containing hydroxylic compounds
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
ES8800842A1 (es) * 1985-03-01 1987-12-01 Beecham Group Plc Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
ZA868891B (en) * 1985-11-27 1988-07-27 Lilly Co Eli Use of phenethanol amines to improve fat content of sow's milk
DE3623940A1 (de) * 1986-07-16 1988-01-21 Bayer Ag Arylethanolhydroxylamine, verfahren zu ihrer herstellung und ihre verwendung zur leistungsfoerderung
DE3631009A1 (de) * 1986-09-12 1988-03-24 Bayer Ag Arylethanolamine, verfahren zu ihrer herstellung und ihre verwendung zur leistungsfoerderung
ES2100148T3 (es) * 1987-09-15 1997-06-16 Rowett Research Inst Aplicaciones terapeuticas de los agonistas beta-adrenergicos.
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β-拟肾上腺素兴奋剂型饲料添加剂的合成方法
CN1082042C (zh) * 1997-06-09 2002-04-03 中国科学院成都有机化学研究所 莱克多巴胺的合成方法
NZ542739A (en) 2003-04-15 2007-02-23 Wellstat Therapeutics Corp Compounds for the treatment of metabolic disorders
WO2005036980A1 (en) * 2003-10-07 2005-04-28 Eli Lilly And Company Liquid formulations of ractopamine
EP2346349B1 (en) * 2008-09-18 2014-11-12 Elanco Animal Health Ireland Limited Use of azaperone for improving growth performance
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
CN102060716A (zh) * 2009-11-15 2011-05-18 海南中化联合制药工业股份有限公司 一种盐酸利托君的制备方法
JP2014524482A (ja) * 2011-08-25 2014-09-22 コグニション セラピューティクス,インコーポレイテッド 神経変性疾患を処置する組成物及び方法
RU2528962C9 (ru) * 2012-12-07 2015-02-20 Государственное научное учреждение Поволжский научно-исследовательский институт производства и переработки мясомолочной продукции Российской академии сельскохозяйственных наук Способ выращивания молодняка свиней
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
EP4023294A1 (en) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating alzheimer's disease
CN104370759B (zh) * 2014-11-13 2016-04-27 上海应用技术学院 一种氘代二甲基莱克多巴胺的制备方法
CN104387282B (zh) * 2014-11-13 2016-09-14 上海应用技术学院 一种氘代莱克多巴胺的制备方法
BR112019023851A2 (pt) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
DE1543918A1 (de) * 1966-01-28 1970-01-08 Troponwerke Dinklage & Co 1-[m-Hydroxyphenyl]-2-[1-methyl-3-phenylpropyl-(1)-amino]-aethanol-(1) und Verfahren zu dessen Herstellung
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
DK268579A (da) * 1978-07-03 1980-01-04 Lilly Co Eli Fremgangsmaade til fremstilling af phenetamolaminer
DK268479A (da) * 1978-07-03 1980-01-04 Lilly Co Eli Fremgangsmaade til fremstilling af r-n-(2-phenyl-2-/hydroxyethyl)-3-phenylpropylaminer
US4391826A (en) * 1978-07-03 1983-07-05 Eli Lilly And Company Phenethanolamines, compositions containing the same, and method for effecting weight control
CA1142954A (en) * 1978-07-03 1983-03-15 Jack Mills Phenethanolamines, compositions containing the same, and method for effecting weight control
DE3104850A1 (de) * 1981-02-11 1982-08-26 Dr. Karl Thomae Gmbh, 7950 Biberach "neuer futterzusatz zur verbesserung des wachstums"
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions

Also Published As

Publication number Publication date
AU577271B2 (en) 1988-09-22
EP0204948B1 (en) 1990-03-28
FI840369A (fi) 1984-08-01
PL245969A1 (en) 1985-01-30
GB2133986B (en) 1987-08-26
GB2133986A (en) 1984-08-08
BG60752B2 (bg) 1996-02-29
GB2177600A (en) 1987-01-28
UA8350A1 (uk) 1996-03-29
JPS59155343A (ja) 1984-09-04
PL144053B1 (en) 1988-04-30
CY1433A (en) 1988-09-02
HUT37012A (en) 1985-11-28
FI81713B (fi) 1990-08-31
SU1523043A3 (ru) 1989-11-15
MX9203041A (es) 1992-07-01
HK39090A (en) 1990-05-25
CA1247451A (en) 1988-12-28
IE840211L (en) 1984-07-31
HU190526B (en) 1986-09-29
GR79758B (da) 1984-10-31
DE3481754D1 (de) 1990-05-03
EP0117647A1 (en) 1984-09-05
CA1275934C (en) 1990-11-06
DK171627B1 (da) 1997-03-03
CY1525A (en) 1990-11-16
GB2177600B (en) 1987-09-03
GB8402343D0 (en) 1984-02-29
AU2391584A (en) 1984-08-02
GB8614772D0 (en) 1986-07-23
FI81713C (fi) 1990-12-10
ZA84721B (en) 1984-09-26
EP0204948A1 (en) 1986-12-17
GT198400014A (es) 1985-07-23
FI840369A0 (fi) 1984-01-30
PH20912A (en) 1987-05-28
IL70813A0 (en) 1984-04-30
SG4190G (en) 1990-07-06
DE3473439D1 (en) 1988-09-22
IL70813A (en) 1987-10-30
MY100559A (en) 1990-11-15
DK41484A (da) 1984-08-01
NZ206985A (en) 1986-09-10
JPH0320225B2 (da) 1991-03-18
IE56843B1 (en) 1992-01-01
EP0117647B1 (en) 1988-08-17

Similar Documents

Publication Publication Date Title
DK41484A (da) Beta-phenethanolaminer og deres anvendelse
DK138185A (da) Eventuelt poroese intumescensmasser og deres anvendelse
DK349088D0 (da) Haerdelige blandinger og deres anvendelse
DK227884D0 (da) 1-pyrimidinyloxy-3-hetarylalkyl-amino-2-propanoler,deres fremstilling og anvendelse
DK594884A (da) Tvaerbundne polymerisater, deres fremstilling og anvendelse
DK373884D0 (da) Herbicide dihydroimidazopyrrolopyridin og derivater heraf
DK35884A (da) Lactampeptider samt deres fremstilling og anvendelse
DK614084D0 (da) Milbemycim-derivater samt deres fremstilling og anvendelse
DK614384A (da) Substituerede imidazoler samt deres fremstilling og anvendelse
DK294684D0 (da) N-alkylerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK558484D0 (da) Milbemycinderivater samt deres fremstilling og anvendelse
DK556483A (da) Benzofuranylderivater og deres fremstilling
DK406384A (da) Imidazobenzodiazepinderivater og disses anvendelse
DK47985D0 (da) Adhaesionsgrunderlakker og deres anvendelse
DK189584D0 (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK419084D0 (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK140684A (da) Phenethanolaminer og deres anvendelse
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
DK35984A (da) Lactampeptider samt deres fremstilling og anvendelse
DK162607C (da) Azopigmentpraeparater og deres anvendelse
DK356481A (da) Hetero-prostaglandinderivater og deres fremstilling
DK613984A (da) 2-heterocyclyl-6-hydroxylavalkyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK181683D0 (da) Arylcycloalkylether-derivater, deres anvendelse og fremstilling
DE3475192D1 (de) Pyrrolizidinones and indolizidones
DK381784A (da) Acylerede hydrazinforbindelser samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired